前收市價 | 4.6500 |
開市 | 4.6500 |
買盤 | 3.4000 |
賣出價 | 4.0500 |
拍板 | 125.00 |
到期日 | 2025-12-19 |
今日波幅 | 4.6500 - 4.6500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 163 |
Eli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
We recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since AbbVie Inc. (NYSE:ABBV) is part of our list, we have analyzed the stock in detail. The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm. Between these two, dividend growth is currently […]